88 FR 132 pgs. 44399-44404 - Importer of Controlled Substances Application: Restek Corporation
Type: NOTICEVolume: 88Number: 132Pages: 44399 - 44404
Pages: 44399, 44400, 44401Docket number: [Docket No. DEA-1223]
FR document: [FR Doc. 2023-14728 Filed 7-11-23; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1223]
Importer of Controlled Substances Application: Restek Corporation
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before August 11, 2023. Such persons may also file a written request for a hearing on the application on or before August 11, 2023.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on February 27, 2023, Restek Corporation, 110 Benner Circle, Bellefonte, Pennsylvania 16823-8433, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
[top]
Controlled Substance | Drug Code | Schedule |
---|---|---|
Amineptine | 1219 | I |
Mesocarb | 1227 | I |
3-Fluoro-N-methylcathinone (3-FMC) | 1233 | I |
Cathinone | 1235 | I |
Methcathinone | 1237 | I |
4-Fluoro-N-methylcathinone (4-FMC) | 1238 | I |
Para-Methoxymethamphetamine (PMMA), 1-(4-1245 I N methoxyphenyl)-N-methylpropan-2-amine | 1245 | I |
Pentedrone (a-methylaminovalerophenone) | 1246 | I |
Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
4-Methyl-N-ethylcathinone (4-MEC) | 1249 | I |
Naphyrone | 1258 | I |
N-Ethylamphetamine | 1475 | I |
Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- 1478 I N amine) | 1478 | I |
N,N-Dimethylamphetamine | 1480 | I |
Fenethylline | 1503 | I |
Aminorex | 1585 | I |
4-Methylaminorex (cis isomer) | 1590 | I |
4,4'-Dimethylaminorex | 1595 | I |
Gamma Hydroxybutyric Acid | 2010 | I |
Methaqualone | 2565 | I |
Mecloqualone | 2572 | I |
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) | 6250 | I |
SR-18 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) 7008 I N SR-18 and RCS-8 indole) SR-19 (1-P | 7008 | I |
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | 7010 | I |
5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) | 7011 | I |
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | 7012 | I |
1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- 7014 I N FUB-144 tetramethylcyclopropyl)methanone | 7014 | I |
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) | 7019 | I |
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | 7020 | I |
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) | 7021 | I |
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide | 7023 | I |
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) | 7024 | I |
5F-AB-PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) | 7025 | I |
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) | 7031 | I |
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) | 7032 | I |
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) | 7033 | I |
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | 7034 | I |
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | 7035 | I |
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) | 7036 | I |
5F-MDMB-PICA | 7041 | |
MDMB-CHMICA, MMB-CHMINACA | 7042 | I |
Methyl 2-7043 I N (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate) | 7043 | I |
MMB-CHMICA | 7044 | I |
FUB-AKB48; FUB-APINACA; AKB48 N-(4-FLUOROBENZYL) | 7047 | I |
APINACA and AKB48 | 7048 | I |
5F-APINACA, 5F-AKB48 | 7049 | I |
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) | 7081 | I |
1-(5-Fluoropentyl)-1H-indazole-3-carboxamide | 7083 | I |
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) | 7085 | I |
4-CN-CUMYL-BUTINACA | 7089 | I |
SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole | 7104 | I |
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) | 7118 | I |
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) | 7122 | I |
UR-144 | 7144 | I |
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) | 7173 | I |
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) | 7200 | I |
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | 7201 | I |
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) | 7203 | I |
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) | 7221 | I |
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | 7222 | I |
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) | 7225 | I |
4-methyl-alpha-ethylaminopentiophenone (4-MEAP) | 7245 | I |
N-ethylhexedrone | 7246 | I |
Alpha-ethyltryptamine | 7249 | I |
Ibogaine | 7260 | I |
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 7286 I N MXE, methoxetamine (methoxetamine) | 7286 | I |
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) | 7297 | I |
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) | 7298 | I |
Lysergic acid diethylamide | 7315 | I |
2,5-Dimethoxy-4-(n)-propylthiophenethylamine | 7348 | I |
Marihuana extract | 7350 | I |
Marihuana | 7360 | I |
Tetrahydrocannabinols | 7370 | I |
Parahexyl | 7374 | I |
Mescaline | 7381 | I |
2C-T-2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) | 7385 | I |
3,4,5-Trimethoxyamphetamine | 7390 | I |
4-Bromo-2,5-dimethoxyamphetamine | 7391 | I |
4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I |
4-Methyl-2,5-dimethoxyamphetamine | 7395 | I |
2,5-Dimethoxyamphetamine | 7396 | I |
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) | 7398 | I |
2,5-Dimethoxy-4-ethylamphetamine | 7399 | I |
3,4-Methylenedioxyamphetamine | 7400 | I |
5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I |
N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I |
3,4-Methylenedioxy-N-ethylamphetamine | 7404 | I |
3,4-Methylenedioxymethamphetamine | 7405 | I |
4-Methoxyamphetamine | 7411 | I |
Peyote | 7415 | I |
5-Methoxy-N-N-dimethyltryptamine | 7431 | I |
Alpha-methyltryptamine | 7432 | I |
Bufotenine | 7433 | I |
Diethyltryptamine | 7434 | I |
Dimethyltryptamine | 7435 | I |
Psilocybin | 7437 | I |
Psilocyn | 7438 | I |
5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) | 7443 | I |
4´-methyl-alpha-pyrrolidinohexiophenone (MPHP) | 7446 | I |
N-Ethyl-1-phenylcyclohexylamine | 7455 | I |
1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I |
1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine | 7473 | I |
N-Ethyl-3-piperidyl benzilate | 7482 | I |
N-Methyl-3-piperidyl benzilate | 7484 | I |
N-Benzylpiperazine | 7493 | I |
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) | 7498 | I |
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) | 7508 | I |
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) | 7509 | I |
2C-H (2-(2,5-Dimethoxyphenyl) ethanamine) | 7517 | I |
2C-I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) | 7518 | I |
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) | 7519 | I |
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) | 7521 | I |
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) | 7524 | I |
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) | 7532 | I |
MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7536 | I |
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7537 | I |
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7538 | I |
Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I |
Butylone | 7541 | I |
Pentylone | 7542 | I |
N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) | 7543 | I |
Alpha-Pyrrolidinohexanophenone | 7544 | I |
a-PVP (alpha-pyrrolidinopentiophenone) | 7545 | I |
a-PBP (alpha-pyrrolidinobutiophenone) | 7546 | I |
Ethylone | 7547 | I |
PV8, alpha-Pyrrolidinoheptaphenone | 7548 | I |
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | 7694 | I |
Acetyldihydrocodeine | 9051 | I |
Benzylmorphine | 9052 | I |
Codeine-N-oxide | 9053 | I |
Cyprenorphine | 9054 | I |
Desomorphine | 9055 | I |
Etorphine (except HCl) | 9056 | I |
Codeine methylbromide | 9070 | I |
Brorphine | 9098 | I |
Dihydromorphine | 9145 | I |
Difenoxin | 9168 | I |
Heroin | 9200 | I |
Hydromorphinol | 9301 | I |
Methyldesorphine | 9302 | I |
Methyldihydromorphine | 9304 | I |
Morphine methylbromide | 9305 | I |
Morphine methylsulfonate | 9306 | I |
Morphine-N-oxide | 9307 | I |
Myrophine | 9308 | I |
Nicocodeine | 9309 | I |
Nicomorphine | 9312 | I |
Normorphine | 9313 | I |
Pholcodine | 9314 | I |
Thebacon | 9315 | I |
Acetorphine | 9319 | I |
Drotebanol | 9335 | I |
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 | I |
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) | 9551 | I |
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) | 9560 | I |
Acetylmethadol | 9601 | I |
Allylprodine | 9602 | I |
Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I |
Alphameprodine | 9604 | I |
Alphamethadol | 9605 | I |
Benzethidine | 9606 | I |
Betameprodine | 9608 | I |
Betamethadol | 9609 | I |
Betaprodine | 9611 | I |
Clonitazene | 9612 | I |
Dextromoramide | 9613 | I |
Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro nitro- 1H-benzimidazol-1-yl)ethan-1-amine) | 9614 | I |
Diampromide | 9615 | I |
Diethylthiambutene | 9616 | I |
Dimenoxadol | 9617 | I |
Dimepheptanol | 9618 | I |
Dimethylthiambutene | 9619 | I |
Dioxaphetyl butyrate | 9621 | I |
Dipipanone | 9622 | I |
Ethylmethylthiambutene | 9623 | I |
Etonitazene | 9624 | I |
Etoxeridine | 9625 | I |
Furethidine | 9626 | I |
Hydroxypethidine | 9627 | I |
Ketobemidone | 9628 | I |
Levomoramide | 9629 | I |
Levophenacylmorphan | 9631 | I |
Morpheridine | 9632 | I |
Noracymethadol | 9633 | I |
Norlevorphanol | 9634 | I |
Normethadone | 9635 | I |
Norpipanone | 9636 | I |
Phenadoxone | 9637 | I |
Phenampromide | 9638 | I |
Phenoperidine | 9641 | I |
Piritramide | 9642 | I |
Proheptazine | 9643 | I |
Properidine | 9644 | I |
Racemoramide | 9645 | I |
Trimeperidine | 9646 | I |
Phenomorphan | 9647 | I |
Propiram | 9649 | I |
1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I |
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | 9663 | I |
Butonitazene | 9751 | I |
Flunitazene | 9756 | I |
METONITAZENE | 9757 | I |
N-PYRROLIDINO ETONITAZENE; ETONITAZEPYNE | 9758 | I |
PROTONITAZENE | 9759 | I |
METODESNITAZENE | 9764 | I |
ETODESNITAZENE; ETAZENE | 9765 | I |
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) | 9811 | I |
Para-Fluorofentanyl | 9812 | I |
3-Methylfentanyl | 9813 | I |
Alpha-Methylfentanyl | 9814 | I |
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | 9816 | I |
Para-Methylfentanyl | 9817 | I |
4'-Methyl Acetyl fentanyl | 9819 | I |
Ortho-Methyl methoxyacetyl fentanyl | 9820 | I |
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 | I |
Butyryl Fentanyl | 9822 | I |
Para-fluorobutyryl fentanyl | 9823 | I |
4-Fluoroisobutyryl fentanyl | 9824 | I |
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide | 9825 | I |
Para-chloroisobutyryl fentanyl | 9826 | I |
Isobutyryl fentanyl | 9827 | I |
Alpha-methylthiofentanyl | 9832 | I |
3-Methylthiofentanyl | 9833 | I |
Furanyl fentanyl | 9834 | I |
Thiofentanyl | 9835 | I |
Beta-hydroxythiofentanyl | 9836 | I |
Para-methoxybutyryl fentanyl | 9837 | I |
Ocfentanil | 9838 | I |
Thiofuranyl fentanyl | 9839 | I |
Valeryl fentanyl | 9840 | I |
Phenyl fentanyl | 9841 | I |
Beta'-Phenyl fentanyl | 9842 | I |
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) | 9843 | I |
Crotonyl fentanyl | 9844 | I |
Cyclopropyl Fentanyl | 9845 | I |
Cyclopentyl fentanyl | 9847 | I |
Ortho-Methyl acetylfentanyl | 9848 | I |
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) | 9850 | I |
Fentanyl Carbamate | 9851 | I |
ORTHO-FLUOROACRYL FENTANYL | 9852 | I |
ORTHO-FLUOROISOBUTYRYL FENTANYL | 9853 | I |
Para-Fluoro furanyl fentanyl | 9854 | I |
2'-Fluoro ortho-fluorofentanyl | 9855 | I |
Beta-Methyl fentanyl | 9856 | I |
Zipeprol | 9873 | I |
Amphetam | 1100 | II |
Methamphetamine | 1105 | II |
Lisdexamfetamine | 1205 | II |
Phenmetrazine | 1631 | II |
Amobarbital | 2125 | II |
Pentobarbital | 2270 | II |
Secobarbital | 2315 | II |
Glutethimide | 2550 | II |
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (FDA) | 7365 | II |
Nabilone | 7379 | II |
1-Phenylcyclohexylamine | 7460 | II |
Phencyclidine | 7471 | II |
ANPP (4-Anilino-N-phenethyl-4-piperidine) | 8333 | II |
Norfentanyl | 8366 | II |
Phenylacetone | 8501 | II |
1-Piperidinocyclohexanecarbonitrile | 8603 | II |
Alphaprodine | 9010 | II |
Anileridine | 9020 | II |
Coca Leaves | 9040 | II |
Cocaine | 9041 | II |
Codeine | 9050 | II |
Etorphine HCl | 9059 | II |
Dihydrocodeine | 9120 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Diphenoxylate | 9170 | II |
Ecgonine | 9180 | II |
Ethylmorphine | 9190 | II |
Hydrocodone | 9193 | II |
Levomethorphan | 9210 | II |
Levorphanol | 9220 | II |
Isomethadone | 9226 | II |
Meperidine | 9230 | II |
Meperidine-intermediate-A | 9232 | II |
Meperidine intermediate-B | 9233 | II |
Meperidine intermediate-C | 9234 | II |
Metazocine | 9240 | II |
Oliceridine | 9245 | II |
Methadone | 9250 | II |
Methadone intermediate | 9254 | II |
Metopon | 9260 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Morphine | 9300 | II |
Oripavine | 9330 | II |
Thebaine | 9333 | II |
Dihydroetorphine | 9334 | II |
Opium, raw | 9600 | II |
Opium extracts | 9610 | II |
Opium fluid extract | 9620 | II |
Opium tincture | 9630 | II |
Opium, powdered | 9639 | II |
Opium, granulated | 9640 | II |
Levo-alphacetylmethadol | 9648 | II |
Opium poppy | 9650 | II |
Oxymorphone | 9652 | II |
Noroxymorphone | 9668 | II |
Poppy Straw Concentrate | 9670 | II |
Phenazocine | 9715 | II |
Thiafentanil | 9729 | II |
Piminodine | 9730 | II |
Racemethorphan | 9732 | II |
Racemorphan | 9733 | II |
Alfentanil | 9737 | II |
Remifentanil | 9739 | II |
Sufentanil | 9740 | II |
Carfentanil | 9743 | II |
Tapentadol | 9780 | II |
Bezitramide | 9800 | II |
Fentanyl | 9801 | II |
Moramide-intermediate | 9802 | II |
The company plans to import analytical reference standards for distribution to its customers for research and analytics purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized in 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-14728 Filed 7-11-23; 8:45 am]
BILLING CODE P